Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Plimack, Elizabeth R."'
Autor:
Powles T; Barts Health NHS Trust and the Royal Free NHS Foundation Trust, Barts Cancer Institute, and Queen Mary University of London, London UK. Electronic address: thomas.powles1@nhs.net., Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA., Soulières D; Centre Hospitalier de l'Universitaire de Montréal, Montréal, QC, Canada., Waddell T; The Christie NHS Foundation Trust, Manchester, UK., Stus V; Dnipropetrovsk Medical Academy of Ministry of Health of Ukraine, Dnipro, Ukraine., Gafanov R; Russian Scientific Center of Roentgenoradiology, Moscow, Russia., Nosov D; Central Clinical Hospital With Outpatient Clinic, Moscow, Russia., Pouliot F; CHU of Québec and Laval University, Québec, QC, Canada., Melichar B; Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic., Vynnychenko I; Sumy State University, Sumy Regional Oncology Center, Sumy Oblast, Ukraine., Azevedo SJ; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Borchiellini D; Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France., McDermott RS; Adelaide and Meath Hospital, Dublin, Ireland; University College Dublin, Dublin, Ireland., Bedke J; University Hospital, Eberhard Karls University Tübingen, Tübingen, Germany., Tamada S; Osaka City University Hospital, Osaka, Japan., Yin L; Merck & Co, Kenilworth, NJ, USA., Chen M; Merck & Co, Kenilworth, NJ, USA., Molife LR; Merck Sharp & Dohme UK, London, UK., Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA., Rini BI; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2020 Dec; Vol. 21 (12), pp. 1563-1573. Date of Electronic Publication: 2020 Oct 23.
Autor:
Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: motzerr@mskcc.org., Rini BI; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA., McDermott DF; Department of Hematology and Medical Oncology, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, MA, USA., Arén Frontera O; Department of Medical Oncology, Centro de Invetigación Clínica Bradford Hill, Santiago, Chile., Hammers HJ; Department of Oncology and Urology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., Carducci MA; Department of Oncology and Urology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., Salman P; Department of Medical Oncology, Fundación Arturo López Pérez, Santiago, Chile., Escudier B; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Beuselinck B; Department of Oncology, University Hospitals Leuven, Leuven, Belgium., Amin A; Levine Cancer Institute, Atrium Healthcare, Charlotte, NC, USA., Porta C; Department of Medical Oncology, IRCCS San Matteo University Hospital Foundation, Pavia, Italy., George S; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA., Neiman V; Department of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel; Tel Aviv University, Tel Aviv, Israel., Bracarda S; Department of Oncology, Ospedale San Donato, Azienda USL Toscana Sud-Est, IstitutoToscanoTumori, Arezzo, Italy., Tykodi SS; Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Barthélémy P; Department of Medical Oncology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Leibowitz-Amit R; Oncology Department, Sheba Medical Center, Ramat Gan, Israel., Plimack ER; Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Redman B; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Melichar B; Department of Oncology, Palacky University, and University Hospital Olomouc, Olomouc, Czech Republic., Powles T; Department of Genitourinary Oncology, Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free National Health Service Trust, London, UK., Nathan P; Department of Cancer Services: Oncology, Mount Vernon Cancer Centre, Northwood, Middlesex, UK., Oudard S; Department of Medical Oncology, Service de Cancérologie Médicale Hôpital Européen Georges Pompidou, Paris, France., Pook D; Department of Oncology, Monash Health, Melbourne, VIC, Australia., Choueiri TK; Department of Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Donskov F; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Grimm MO; Department of Urology, Jena University Hospital, Jena, Germany., Gurney H; Department of Medical Oncology, Westmead Hospital and Macquarie University, Sydney, NSW, Australia., Heng DYC; Department of Oncology, Tom Baker Cancer Center, University of Calgary, Calgary, AB, Canada., Kollmannsberger CK; Department of Medicine, British Columbia Cancer Agency, Vancouver, BC, Canada., Harrison MR; Division of Medical Oncology, Duke Cancer Institute, Durham, NC, USA., Tomita Y; Department of Urology, Niigata University, Niigata, Japan., Duran I; Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain., Grünwald V; Interdisciplinary Genitourinary Oncology at the West-German Cancer Center, Clinic for Internal Medicine (Tumor Research) and Clinic for Urology, University Hospital Essen, Essen, Germany., McHenry MB; Bristol-Myers Squibb, Princeton, NJ, USA., Mekan S; Bristol-Myers Squibb, Princeton, NJ, USA., Tannir NM; Department of Genitourinary Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 Oct; Vol. 20 (10), pp. 1370-1385. Date of Electronic Publication: 2019 Aug 16.
Autor:
Martínez Chanzá N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Xie W; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Asim Bilen M; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Dzimitrowicz H; Duke Cancer Center, Durham, NC, USA., Burkart J; Department of Medicine, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Geynisman DM; Fox Chase Cancer Center, Philadelphia, PA, USA., Balakrishnan A; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA., Bowman IA; University of Texas Southwestern Medical Center, Dallas, TX, USA., Jain R; Roswell Park Cancer Institute, Buffalo, NY, USA., Stadler W; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Zakharia Y; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA., Narayan V; Abramson Cancer Center, Philadelphia, PA, USA., Beuselinck B; Leuven Cancer Institute, Universitair Ziekenhuis, Leuven, Leuven, Belgium., McKay RR; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Tripathi A; Stephenson Cancer Center, Oklahoma City, OK, USA., Pachynski R; Washington University School of Medicine, St Louis, MO, USA., Hahn AW; Huntsman Cancer Institute, Salt Lake City, UT, USA., Hsu J; City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Shah SA; Stanford Cancer Institute, Palo Alto, CA, USA., Lam ET; University of Colorado Cancer Center, Aurora, CO, USA., Rose TL; University of North Carolina Lineberger Cancer Comprehensive Center, Chapel Hill, NC, USA., Mega AE; Lifespan Cancer Institute, Alpert Medical School, Brown University, Providence, RI, USA., Vogelzang N; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA., Harrison MR; Duke Cancer Center, Durham, NC, USA., Mortazavi A; Department of Medicine, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA., Vaishampayan U; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA., Hammers H; University of Texas Southwestern Medical Center, Dallas, TX, USA., George S; Roswell Park Cancer Institute, Buffalo, NY, USA., Haas N; Abramson Cancer Center, Philadelphia, PA, USA., Agarwal N; Huntsman Cancer Institute, Salt Lake City, UT, USA., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Srinivas S; Stanford Cancer Institute, Palo Alto, CA, USA., Carneiro BA; Lifespan Cancer Institute, Alpert Medical School, Brown University, Providence, RI, USA., Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Bosse D; The Ottawa Hospital Cancer Center, University of Ottawa, Ottawa, ON, Canada., Choueiri TK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Harshman LC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: LaurenC_Harshman@dfci.harvard.edu.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 Apr; Vol. 20 (4), pp. 581-590. Date of Electronic Publication: 2019 Feb 28.
Autor:
Atkins MB; Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. Electronic address: mba41@georgetown.edu., Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA., Puzanov I; Vanderbilt University Medical Center, Nashville, TN, USA; Roswell Park Cancer Institute, Buffalo, NY, USA., Fishman MN; Moffitt Cancer Center, Tampa, FL, USA., McDermott DF; Beth Israel Deaconess Medical Center, Boston, MA, USA., Cho DC; New York University Langone Medical Center, New York, NY, USA., Vaishampayan U; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., George S; Roswell Park Cancer Institute, Buffalo, NY, USA., Olencki TE; Ohio State University Wexner Medical Center, Columbus, OH, USA., Tarazi JC; Pfizer Oncology, San Diego, CA, USA., Rosbrook B; Pfizer Oncology, San Diego, CA, USA., Fernandez KC; Pfizer Oncology, Cambridge, MA, USA., Lechuga M; Pfizer SrL, Milan, Italy., Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2018 Mar; Vol. 19 (3), pp. 405-415. Date of Electronic Publication: 2018 Feb 10.
Autor:
Balar AV; Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY, USA. Electronic address: arjun.balar@nyumc.org., Castellano D; Hospital Universitario 12 de Octubre (CiberOnc), Madrid, Spain., O'Donnell PH; University of Chicago Medical Center, Chicago, IL, USA., Grivas P; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Vuky J; Oregon Health & Science University, Portland, OR, USA., Powles T; Barts Cancer Institute, Queen Mary University of London, London, UK., Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA., Hahn NM; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., de Wit R; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Pang L; Merck & Co, Kenilworth, NJ, USA., Savage MJ; Merck & Co, Kenilworth, NJ, USA., Perini RF; Merck & Co, Kenilworth, NJ, USA., Keefe SM; Merck & Co, Kenilworth, NJ, USA., Bajorin D; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bellmunt J; Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2017 Nov; Vol. 18 (11), pp. 1483-1492. Date of Electronic Publication: 2017 Sep 26.
Autor:
Sharma P; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA; Department of Immunology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. Electronic address: padsharma@mdanderson.org., Retz M; Department of Urology, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany., Siefker-Radtke A; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Baron A; Department of Medicine, California Pacific Medical Center, San Francisco, CA, USA., Necchi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bedke J; Department of Urology, University of Tübingen, Tübingen, Germany., Plimack ER; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Vaena D; Division of Hematology, Oncology, and Bone Marrow Transplantation/Department of Medicine and Urology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA., Grimm MO; Department of Urology, Jena University Hospital, Jena, Germany., Bracarda S; Department of Oncology and Medical Oncology Unit, Ospedale San Donato, Azienda USL Toscana Sud-Est, Istituto Toscano Tumori, Arezzo, Italy., Arranz JÁ; Genitourinary and Gynecologic Section, Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Pal S; Kidney Cancer Program, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Ohyama C; Department of Urology, Hirosaki University, Hirosaki, Aomori, Japan., Saci A; Exploratory Clinical & Translational Research Department, Bristol-Myers Squibb, Princeton, NJ, USA., Qu X; Translational Bioinformatics Department, Bristol-Myers Squibb, Princeton, NJ, USA., Lambert A; Biometrics Department, Bristol-Myers Squibb, Braine-l'Alleud, Belgium., Krishnan S; Global Clinical Research Oncology Department, Bristol-Myers Squibb, Princeton, NJ, USA., Azrilevich A; Global Clinical Research Oncology Department, Bristol-Myers Squibb, Princeton, NJ, USA., Galsky MD; Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, New York, NY, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2017 Mar; Vol. 18 (3), pp. 312-322. Date of Electronic Publication: 2017 Jan 26.
Autor:
Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: elizabeth.plimack@fccc.edu., Bellmunt J; Dana-Farber Cancer Institute, Boston, MA, USA., Gupta S; University of Minnesota, Minneapolis, MN, USA., Berger R; Chaim Sheba Medical Center at Tel Hashomer, Tel-Hashomer, Ramat-Gan, Israel., Chow LQ; University of Washington, Seattle, WA, USA., Juco J; Merck & Co., Inc. Kenilworth, NJ, USA., Lunceford J; Merck & Co., Inc. Kenilworth, NJ, USA., Saraf S; Merck & Co., Inc. Kenilworth, NJ, USA., Perini RF; Merck & Co., Inc. Kenilworth, NJ, USA., O'Donnell PH; University of Chicago, Chicago, IL, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2017 Feb; Vol. 18 (2), pp. 212-220. Date of Electronic Publication: 2017 Jan 10.
Autor:
Rini BI; Cleveland Clinic Taussig Cancer Institute, Main Campus, Cleveland, OH, USA. Electronic address: rinib2@ccf.org., Dorff TB; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Elson P; Cleveland Clinic Taussig Cancer Institute, Main Campus, Cleveland, OH, USA., Rodriguez CS; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Shepard D; Cleveland Clinic Taussig Cancer Institute, Main Campus, Cleveland, OH, USA., Wood L; Cleveland Clinic Taussig Cancer Institute, Main Campus, Cleveland, OH, USA., Humbert J; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Pyle L; Royal Marsden NHS Foundation Trust, London, UK., Wong YN; Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA., Finke JH; Cleveland Clinic Taussig Cancer Institute, Main Campus, Cleveland, OH, USA., Rayman PA; Cleveland Clinic Taussig Cancer Institute, Main Campus, Cleveland, OH, USA., Larkin JM; Royal Marsden NHS Foundation Trust, London, UK., Garcia JA; Cleveland Clinic Taussig Cancer Institute, Main Campus, Cleveland, OH, USA., Plimack ER; Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2016 Sep; Vol. 17 (9), pp. 1317-24. Date of Electronic Publication: 2016 Aug 03.